Inflammation as a therapeutic target in heart failure with preserved ejection fraction

Heart failure with preserved ejection fraction (HFpEF) accounts for around half of all cases of heart failure and may become the dominant type of heart failure in the near future. Unlike HF with reduced ejection fraction there are few evidence-based treatment strategies available. There is a signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Peh, Zhen Hui, Dihoum, Adel, Hutton, Dana, Arthur, J. Simon C., Rena, Graham, Khan, Faisel, Lang, Chim C., Mordi, Ify R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339321/
https://www.ncbi.nlm.nih.gov/pubmed/37456816
http://dx.doi.org/10.3389/fcvm.2023.1125687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339321/
https://www.ncbi.nlm.nih.gov/pubmed/37456816
http://dx.doi.org/10.3389/fcvm.2023.1125687

Ejemplares similares